Radiation boost may extend life for patients with limited spread lung cancer

NCT ID NCT05278052

Recruiting now Disease control Sponsor: Tata Memorial Hospital Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 26 times

Summary

This study tests whether adding targeted radiation to standard maintenance therapy can help people with non-small cell lung cancer that has spread to 1-5 spots live longer. About 190 adults with stable disease after initial chemotherapy will be randomly assigned to standard therapy alone or standard therapy plus radiation. The goal is to see if the combination improves overall survival and delays cancer progression.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC NON-SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Tata Memorial Hospital, Parel
RECRUITING

Mumbai, Maharashtra, 400012, India

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

METASTATIC NON-SMALL CELL LUNG CANCER OLIGOMETASTATIC DISEASE